Phathom Pharmaceuticals, Inc. (PHAT)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

100 CAMPUS DRIVE, FLORHAM PARK, NJ 07932

Phathom Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal diseases and disorders. Phathom has in-licensed the exclusive rights in the United States, Europe, and Canada to vonoprazan, a novel potassium competitive acid blocker (P-CAB) in late-stage development for the treatment of acid-related disorders.

Data as of 2021-10-17 10:31:20 -0400
Market Cap1.019 Billion Shares Outstanding31.356 Million Avg 30-day Volume73.382 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-8.16 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.14561 52-week High/Low50.78 / 29.79 Next Earnings Date2021-11-09 Price to Cash FLow (P/CF) -28.6556
Data provided by IEX Cloud
View SEC Filings from PHAT instead.

View recent insider trading info

Funds Holding PHAT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PHAT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

36 Thousand total shares from 5 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SOCKS DAVID A

  • Director
2,425,631 2021-10-07 13

PARIKH ASIT

  • Director
7,500 2021-07-13 2

TAKEDA PHARMACEUTICAL CO LTD

  • 10% Owner
871,305 2021-07-07 19

GUZZO ANTHONY J. VP, CHIEF ACCOUNTING OFFICER

  • Officer
804 2021-06-04 1

FIELDS HEIDI

  • Director
12,500 2021-05-21 1

COLA MICHAEL F

  • Director
12,500 2021-05-21 1

YAMADA TADATAKA

  • Director
12,500 2021-05-21 1

STENHOUSE MARK

  • Director
12,500 2021-05-21 1

NABULSI AZMI CHIEF OPERATING OFFICER

  • Officer
765,700 2021-05-03 8

CURRAN TERRIE PRESIDENT AND CHIEF EXECUTIVE

  • Officer
  • Director
855,687 2021-03-22 2

RA CAPITAL MANAGEMENT, L.P.

RA CAPITAL HEALTHCARE FUND LP

KOLCHINSKY PETER

SHAH RAJEEV M.

  • 10% Owner
No longer subject to file 2021-03-11 1

BRANNING TODD P. CHIEF FINANCIAL OFFICER

  • Officer
0 2021-01-28 1

FRAZIER LIFE SCIENCES IX, L.P.

FHMLS IX, L.P.

FHMLS IX, L.L.C.

TOPPER JAMES N

HERON PATRICK J

  • Director
  • 10% Owner
5,858,861 2020-06-12 0

TOPPER JAMES N

  • Director
  • 10% Owner
0 2020-05-21 0

EDWARDS JONATHAN S.

  • Director
3,083,091 2019-10-29 0

KOHLI ADITYA CHIEF BUSINESS OFFICER

  • Officer
843,352 2019-10-24 0

SLAVINSKY CHRISTOPHER W.

  • Director
0 2019-10-24 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

SOCKS DAVID A - Director david a. socks 2013 revocable trust

2021-10-08 18:28:55 -0400 2021-10-08 S 2,529 $32.05 d 1,211,346 indirect 3.5614 3.5614 2 0.0 1

SOCKS DAVID A - Director david a. socks 2013 revocable trust

2021-10-08 18:28:55 -0400 2021-10-07 S 15,471 $32.66 d 1,213,875 indirect yes 3.5614 3.5614 2 0.0 1

SOCKS DAVID A - Director david a. socks 2013 revocable trust

2021-09-23 20:37:13 -0400 2021-09-22 S 4,100 $32.06 d 1,229,346 indirect 3.2633 1.161 3.2633 2 -0.8472 4

SOCKS DAVID A - Director david a. socks 2013 revocable trust

2021-09-23 20:37:13 -0400 2021-09-21 S 13,576 $32.79 d 1,233,770 indirect yes 3.2633 1.161 3.2633 2 -0.8472 4

SOCKS DAVID A - Director david a. socks 2013 revocable trust

2021-09-23 20:37:13 -0400 2021-09-21 S 324 $33.31 d 1,233,446 indirect 3.2633 1.161 3.2633 2 -0.8472 4

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
PHATHOM PHARMACEUTICALS INC PHAT 2021-10-18 22:15:03 UTC -0.2906 0.3606 250000
PHATHOM PHARMACEUTICALS INC PHAT 2021-10-18 21:45:03 UTC -0.2906 0.3606 250000
PHATHOM PHARMACEUTICALS INC PHAT 2021-10-18 21:15:03 UTC -0.2906 0.3606 250000
PHATHOM PHARMACEUTICALS INC PHAT 2021-10-18 20:45:03 UTC -0.2906 0.3606 250000
PHATHOM PHARMACEUTICALS INC PHAT 2021-10-18 20:15:03 UTC -0.2906 0.3606 250000
PHATHOM PHARMACEUTICALS INC PHAT 2021-10-18 19:45:03 UTC -0.2906 0.3606 250000
PHATHOM PHARMACEUTICALS INC PHAT 2021-10-18 19:15:03 UTC -0.2906 0.3606 250000
PHATHOM PHARMACEUTICALS INC PHAT 2021-10-18 18:45:02 UTC -0.2906 0.3606 250000
PHATHOM PHARMACEUTICALS INC PHAT 2021-10-18 18:15:03 UTC -0.2906 0.3606 250000
PHATHOM PHARMACEUTICALS INC PHAT 2021-10-18 17:45:03 UTC -0.2906 0.3606 250000
PHATHOM PHARMACEUTICALS INC PHAT 2021-10-18 17:15:03 UTC -0.2906 0.3606 250000
PHATHOM PHARMACEUTICALS INC PHAT 2021-10-18 16:45:03 UTC -0.2906 0.3606 250000
PHATHOM PHARMACEUTICALS INC PHAT 2021-10-18 16:15:03 UTC -0.2906 0.3606 250000
PHATHOM PHARMACEUTICALS INC PHAT 2021-10-18 15:45:03 UTC -0.2906 0.3606 250000
PHATHOM PHARMACEUTICALS INC PHAT 2021-10-18 15:15:03 UTC -0.2906 0.3606 250000
PHATHOM PHARMACEUTICALS INC PHAT 2021-10-18 14:45:03 UTC -0.2919 0.3619 250000
PHATHOM PHARMACEUTICALS INC PHAT 2021-10-18 14:15:03 UTC -0.2919 0.3619 250000
PHATHOM PHARMACEUTICALS INC PHAT 2021-10-18 13:45:04 UTC -0.2919 0.3619 250000
PHATHOM PHARMACEUTICALS INC PHAT 2021-10-18 13:15:03 UTC -0.2919 0.3619 250000
PHATHOM PHARMACEUTICALS INC PHAT 2021-10-18 12:45:03 UTC -0.2919 0.3619 250000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments